Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/1991
02/19/1991US4994481 For binding to lymphocyte membranes, masking receptivity to virus
02/19/1991CA2023485A1 Macrocyclic compounds
02/17/1991CA2020700A1 Compositions for the inhibition of protein hormone formation and uses thereof
02/16/1991WO1991002747A1 Tuftsin analogs
02/16/1991CA2064731A1 Tuftsin analogs
02/13/1991EP0412941A2 Phospholipids for the treatment of multiple sclerosis
02/13/1991EP0412939A2 Certain benzopyran and benzothiopyran derivatives
02/13/1991EP0412542A2 Cyclic neurokinin antagonists
02/13/1991EP0412387A2 Diarylacetylenes, their process and use
02/13/1991CN1049156A Indenoindole compounds i
02/12/1991US4992574 Benzocycloheptene derivatives
02/12/1991US4992468 Treatment of skin disorders
02/12/1991US4992367 Genetic engineering
02/12/1991CA2023016A1 Certain benzopyran and benzothiopyran derivatives
02/12/1991CA1280115C Benzo b thiophen and benzo b furancarboxamides, their preparation and medicaments comprising the same
02/12/1991CA1280113C Tricyclic dibenzo condensed derivatives and process for their preparation
02/11/1991WO1991001730A2 Use of xanthine-derivatives as inhibitors of induced blood eosinophilia
02/11/1991CA2064792A1 Treatment
02/09/1991CA2022570A1 Diarylacetylenes, the preparation and use thereof
02/07/1991WO1991001137A1 Antiviral composition
02/07/1991WO1991001134A1 Novel lipid a derivatives and uses therefor
02/07/1991WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease
02/07/1991WO1990014068A3 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
02/07/1991DE3925183A1 Proteine mit tnf-wirkung Proteins with tnf-effective
02/06/1991EP0411946A2 DNA encoding human GP130 protein
02/06/1991EP0411394A1 Imidazoquinolone derivates
02/06/1991EP0411048A1 Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use
02/06/1991EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1)
02/06/1991EP0233946B1 Chromoglycic acid derivatives, process for their preparation, and medicinal composition
02/05/1991US4990530 Indomethacin injections and their production method
02/03/1991WO1991002000A1 Il-2 deletion mutants
02/03/1991CA2064696A1 Il-2 deletion mutants
01/1991
01/30/1991WO1991001998A1 Proteins with tnf activity
01/30/1991EP0410813A1 Anti-human BCDF monoclonal antibody and immunoassay using the same
01/30/1991EP0410750A2 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia.
01/30/1991EP0410742A1 Phenylethenyl compounds having retinoid-like activity
01/30/1991EP0410661A2 Bicyclic derivatives
01/30/1991EP0410389A1 Indolocarbazol and its use
01/30/1991EP0410358A1 Aromatic carboxylic acid amides, their preparation and their use as medicines
01/30/1991EP0409957A1 Biological fluids purification systems
01/30/1991EP0409893A1 Magnetically influenced homeopathic pharmaceutical formulations and methods of their preparation
01/30/1991EP0321548A4 Novel amphiphilic nucleic acid conjugates
01/30/1991EP0236390B1 Agent against multiple sclerosis
01/30/1991CA2051124A1 Proteins with tnf activity
01/29/1991WO1991001751A1 Biological preparation and its use
01/29/1991WO1991001741A1 Extracts of the acanthospermum hispidum plant
01/29/1991WO1991001726A1 Method of preventing graft rejection in solid organ transplantation
01/29/1991US4988733 N-[1-(3-phenoxyphenyl)ethyl]acetohydroxamic acid compounds which are useful anti-inflammatory agents
01/29/1991US4988701 Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions
01/29/1991US4988680 Phosphorylase inhibitors, immuno suppressants, parasiticides, antileukemia agents
01/29/1991CA2035031A1 Extracts of the acanthospermum hispidum plant
01/29/1991CA2020887A1 Aromatic carboxylic amides
01/27/1991CA2020253A1 Phenylethenyl compounds having retinoid-like activity
01/24/1991WO1991000855A1 Novel vitamin d analogues
01/23/1991EP0409662A2 Zinc spray preparations
01/23/1991EP0409484A2 4,5,6,7-Tetrasubstituted benzoxazolones
01/23/1991EP0409414A1 Diaryl ether cycloalkanes
01/23/1991EP0409413A2 Diaryl ether heterocycles
01/23/1991EP0409412A2 Diaryl ether cyclic ethers
01/23/1991EP0409410A1 Indenoindole compounds
01/23/1991EP0409163A2 Novel cyclic vinylogous N-hydroxy-N-methylureas useful as 5-lipoxygenase inhibitors
01/23/1991EP0409119A1 N,N'-Bis(alkoxy-alkyl)-pyridine-2,4-dicarboxylic acid amides, process for their preparation as well as their use
01/23/1991EP0409027A1 Indole derivatives, process for their preparation and their use in pharmaceuticals
01/23/1991EP0408859A2 Monoclonal antibodies to activated endothelial cells
01/23/1991EP0408651A1 Isoferritin as a marker for pathological pregnancy
01/22/1991WO1991002050A1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
01/22/1991WO1991002002A1 Recombinantly produced human membrane cofactor protein (mcp)
01/22/1991WO1991001370A1 Protection of nk cell cytolytic activity in pbmc
01/22/1991WO1991001369A1 Preparation of human adherent lymphokine-activated killer (a-lak) cells
01/22/1991CA2064072A1 Preparation of human adherent lymphokine-activated killer (a-lak) cells
01/22/1991CA2063813A1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
01/22/1991CA2063788A1 Protection of nk cell cytolytic activity in pbmc
01/22/1991CA2021560A1 Indole derivatives, a process for their preparation and their use in medicaments
01/21/1991CA2021421A1 4, 5, 6, 7, - tetrasubstituted benzoxazolones
01/18/1991CA2019543A1 Diaryl ether cyclic ethers
01/18/1991CA2019345A1 Diaryl ether heterocycles
01/18/1991CA2019344A1 Diaryl ether cycloalkanes
01/16/1991EP0408444A2 Galactan extracted Klebsiella, process for its preparation and its use as a medicament
01/16/1991EP0408371A1 Hemoregulatory peptides
01/16/1991EP0408044A2 Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
01/16/1991EP0407955A1 New hetrazepines acting as PAF antagonists, process for their production and their use as drugs
01/16/1991EP0407788A2 Use of retinoids for the treatment and prophylaxis of immune related diseases
01/16/1991EP0407780A2 Ranolazine and related piperazines used in the treatment of tissues experiencing a physical or chemical insult
01/16/1991EP0407701A2 Antiretroviral pyrroline and pyrrolidine sulfonic acid derivatives
01/16/1991EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions
01/16/1991CN1048496A Aqueous liquid composition for external use
01/15/1991WO1991001333A1 Methods of treating or preventing autoimmune uveoretinitis in mammals
01/15/1991US4985447 Certain benzoquinones, naphthoquinones and derivatives thereof which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like
01/15/1991US4985405 Therapeutic product based on organic silicon derivatives
01/14/1991WO1991001123A2 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d¿4?
01/14/1991CA2036381A1 Quinolinyl-benzopyran derivatives as antagonists of leukotriene d4
01/13/1991CA2020806A1 Thienodiazepine derivatives
01/12/1991CA2020794A1 Galactanne extracted from klebsiella, process for its obtention and use as medicament
01/10/1991WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
01/10/1991WO1991000271A1 Novel vitamin d analogues
01/10/1991WO1990014427A3 Multivalent repressor of gene function
01/09/1991EP0407092A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same
01/09/1991EP0407000A2 Aqueous preparation of an pyrido[1,2-a] pyrimidine compound
01/09/1991EP0406931A2 New analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions
01/09/1991EP0406791A2 Aqueous liquid composition for external use